{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:48:12Z","timestamp":1783547292537,"version":"3.55.0"},"reference-count":13,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2018,2,6]]},"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1136\/ejhpharm-2017-001454","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T20:40:33Z","timestamp":1519850433000},"page":"210-213","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Tolerance and safety of rapid 2-hour infusion of rituximab in patients with kidney-affecting autoimmune diseases and glomerulonephritides: a single-centre experience"],"prefix":"10.1136","volume":"26","author":[{"given":"Jan Miroslav","family":"Hartinger","sequence":"first","affiliation":[{"name":"Institute of Pharmacology, Department of Clinical Pharmacology and Pharmacy, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Satrapov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"Hru\u0161kov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Tesa\u0159","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"2025090703343430000_26.4.210.1","first-page":"148","article-title":"Impact of rituximab (rituxan) on the treatment of B-cell non-Hodgkin\u2019s lymphoma","volume":"35","author":"Dotan","year":"2010","journal-title":"P T"},{"key":"2025090703343430000_26.4.210.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2008.10.004"},{"key":"2025090703343430000_26.4.210.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2005.05.007"},{"key":"2025090703343430000_26.4.210.4","unstructured":"Roche_Registration_Limited. Mabthera (rituximab) package insert, 2008."},{"key":"2025090703343430000_26.4.210.5","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.200001"},{"key":"2025090703343430000_26.4.210.6","doi-asserted-by":"publisher","DOI":"10.1188\/10.CJON.E10-E21"},{"key":"2025090703343430000_26.4.210.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/629283","article-title":"Rapid infusion rituximab for maintenance therapy: is it feasible?","volume":"2013","author":"Patel","year":"2013","journal-title":"Leuk Res Treatment"},{"key":"2025090703343430000_26.4.210.8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-177"},{"key":"2025090703343430000_26.4.210.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2208-0"},{"key":"2025090703343430000_26.4.210.10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/phar.1420","article-title":"Use of a pharmacy protocol to convert standard rituximab infusions to rapid infusion shortens outpatient infusion clinic visits","volume":"34","author":"Swan","year":"2014","journal-title":"Pharmacotherapy"},{"key":"2025090703343430000_26.4.210.11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10067-012-2094-1","article-title":"Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience","volume":"32","author":"Can","year":"2013","journal-title":"Clin Rheumatol"},{"key":"2025090703343430000_26.4.210.12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq436"},{"key":"2025090703343430000_26.4.210.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.25000"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2017-001454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:34:45Z","timestamp":1757241285000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2017-001454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,6,28]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/ejhpharm-2017-001454"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2017-001454","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]}}}